Get the Stockscreener App
1.83
1.61%
-0.03
After Hours:
1.86
0.03
+1.64%
Inmune Bio Inc stock is traded at $1.83, with a volume of 474.06K.
It is down -1.61% in the last 24 hours and down -8.96% over the past month.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
See More
Previous Close:
$1.86
Open:
$1.89
24h Volume:
474.06K
Relative Volume:
0.35
Market Cap:
$48.65M
Revenue:
$155.00K
Net Income/Loss:
$-30.01M
P/E Ratio:
-1.0958
EPS:
-1.67
Net Cash Flow:
$-11.98M
1W Performance:
-11.17%
1M Performance:
-8.96%
6M Performance:
-75.20%
1Y Performance:
-64.40%
1-Day Range:
$1.82
$1.90
1-Week Range:
$1.82
$2.0993
52-Week Range:
$1.71
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
Name
Inmune Bio Inc
Sector
Industry
Phone
(858) 964-3720
Address
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Compare INMB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.83 | 49.45M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-01-25 | Downgrade | Scotiabank | Sector Outperform → Sector Underperform |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Oct-21-24 | Initiated | Alliance Global Partners | Buy |
| Sep-27-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Scotiabank | Sector Outperform |
| Jun-01-23 | Initiated | Robert W. Baird | Outperform |
| May-24-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jul-07-21 | Reiterated | Maxim Group | Buy |
| Apr-21-21 | Initiated | B. Riley Securities | Buy |
| Jan-22-21 | Reiterated | Maxim Group | Buy |
| Sep-01-20 | Initiated | BTIG Research | Buy |
| Jul-15-20 | Reiterated | H.C. Wainwright | Buy |
View All
Inmune Bio Inc Stock (INMB) Latest News
Can volume confirm reversal in INmune Bio Inc.July 2025 Closing Moves & Weekly Market Pulse Alerts - newser.com
Will INmune Bio Inc. stock outperform tech sector in 2025Weekly Gains Summary & Long Hold Capital Preservation Plans - newser.com
How INmune Bio Inc. stock benefits from global expansionGlobal Markets & Daily Technical Forecast Reports - newser.com
INmune Bio Inc Stock Analysis and ForecastCandlestick Trading Patterns & Free Rapid Profit Acceleration - earlytimes.in
INmune Bio Inc. stock trend outlook and recovery pathMarket Risk Analysis & High Accuracy Swing Entry Alerts - newser.com
How to track smart money flows in INmune Bio Inc.July 2025 EndofMonth & Reliable Trade Execution Plans - newser.com
What does recent volatility data suggest for INmune Bio Inc.Portfolio Performance Summary & AI Driven Price Forecasts - newser.com
INmune Bio (NASDAQ:INMB) Receives "Sell (E+)" Rating from Weiss Ratings - MarketBeat
INmune Bio, Inc. (NASDAQ:INMB) Receives Average Rating of "Hold" from Analysts - MarketBeat
Using RSI to spot recovery in INmune Bio Inc.Market Weekly Review & Weekly High Conviction Ideas - newser.com
Analyzing INmune Bio Inc. with risk reward ratio chartsGDP Growth & Safe Capital Growth Tips - newser.com
Predicting INmune Bio Inc. trend using moving averagesJuly 2025 Action & Target Return Focused Picks - newser.com
Inmune Bio Submits Manuscript on Alzheimer’s Trial - TipRanks
INmune Bio submits manuscript on Phase 2 Alzheimer’s trial results - Investing.com
Inmune Bio announces submission of phase 2 mindful trial results in Alzheimer's - MarketScreener
INmune Bio submits manuscript on Phase 2 Alzheimer’s trial results By Investing.com - Investing.com Australia
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal - Yahoo Finance
What analysts say about INmune Bio Inc stockTechnical Breakout Signals & Free Daily Stock Hotspot Analysis - Early Times
AI Stocks: Whats the profit margin of INmune Bio IncJuly 2025 Retail & Community Consensus Stock Picks - خودرو بانک
Analysis Recap: Is INmune Bio Inc. forming a double bottomEarnings Summary Report & Fast Moving Market Watchlists - خودرو بانک
INmune Bio, Inc. (NASDAQ:INMB) Short Interest Update - MarketBeat
Aug Macro: Whats the profit margin of INmune Bio IncEarnings Risk Summary & High Accuracy Trade Alerts - khodrobank.com
How does Battalion Oil Corporation compare to its peersWeekly Investment Report & AI Enhanced Trading Signals - khodrobank.com
INmune Bio, Inc. (NASDAQ:INMB) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Risk Analysis: Can INmune Bio Inc stock outperform in a bear marketJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - خودرو بانک
Will INmune Bio Inc outperform the market in YEAR2025 Biggest Moves & Weekly Stock Performance Updates - خودرو بانک
Block Trades: What are INmune Bio Incs earnings expectationsQuarterly Growth Report & Safe Entry Zone Identification - khodrobank.com
Has INmune Bio Inc. formed a bullish divergenceJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Retail Surge: Is INmune Bio Inc a stock for growth or value investorsQuarterly Investment Review & AI Driven Stock Reports - خودرو بانک
Aug Macro: Is INmune Bio Inc. impacted by rising rates2025 Geopolitical Influence & AI Based Trade Execution Alerts - خودرو بانک
INmune Bio, Inc. (NASDAQ:INMB) Receives $18.40 Consensus PT from Analysts - Defense World
Loss Report: Can INmune Bio Inc stock outperform in a bear marketWeekly Profit Analysis & Scalable Portfolio Growth Methods - خودرو بانک
VIX Spike: Is INmune Bio Inc stock undervalued right nowJuly 2025 Rallies & Reliable Trade Execution Plans - خودرو بانک
Meme Stocks: How is i 80 Gold Corp managing supply chain issuesEarnings Summary Report & Daily Chart Pattern Signal Reports - خودرو بانک
Aug Summary: Will INmune Bio Inc benefit from geopolitical trendsJuly 2025 EndofMonth & Capital Efficient Trade Techniques - خودرو بانک
Aug Outlook: Is INmune Bio Inc a stock for growth or value investorsJuly 2025 Chart Watch & Accurate Intraday Trade Tips - khodrobank.com
Breakout Move: Can INmune Bio Inc expand into new marketsInsider Buying & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Bearish Setup: Is INmune Bio Inc stock a value trapNew Guidance & Weekly Breakout Opportunity Watchlist - خودرو بانک
Risks Report: Is INmune Bio Inc. stock a falling knife or bargain buyWeekly Investment Summary & Accurate Entry and Exit Point Alerts - خودرو بانک
Published on: 2025-09-16 12:20:17 - خودرو بانک
Aug Macro: Will INmune Bio Inc. benefit from rate cutsJuly 2025 Update & Consistent Profit Trade Alerts - خودرو بانک
Will INmune Bio Inc benefit from geopolitical trendsWeekly Loss Report & Consistent Growth Stock Picks - خودرو بانک
Inmune Bio Inc Stock (INMB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):